Recommended Immunization Schedule for Persons Aged 0 Through 6 Years
—United States • 2010For those who fall behind or start late, see the catch-up schedule
Vaccine ▼
Age ►
Birth
1
month
2
months
4
months
6
months
12
months
15
months
18
months
19–23
months
2–3
years
4–6
years
Hepatitis B
1
HepB
HepB HepB
Rotavirus
2
RV RV RV
2
3
see
Range of
recommended
Diphtheria, Tetanus, Pertussis
DTaP DTaP DTaP
footnote
3
DTaP DTaP
ages for all
Haemophilus influenzae type b
4
Hib Hib
Hib
4
Hib
children except
certain high-risk
Pneumococcal
5
PCV PCV PCV
Inactivated Poliovirus
6
IPV IPV
Influenza
7
Measles, Mumps, Rubella
8
Varicella
9
PCV
IPV
MMR
Varicella
Influenza (Yearly)
see footnote
8
see footnote
9
PPSV
IPV
MMR
Varicella
groups
Range of
recommended
ages for certain
high-risk groups
Hepatitis A
10
Meningococcal
11
HepA (2 doses)
HepA Series
MCV
This schedule includes recommendations in effect as of December 15, 2009.
Any dose not administered at the recommended age should be administered at a
subsequent visit, when indicated and feasible. The use of a combination vaccine
generally is preferred over separate injections of its equivalent component vaccines.
Considerations should include provider assessment, patient preference, and
the potential for adverse events. Providers should consult the relevant Advisory
Committee on Immunization Practices statement for detailed recommendations:
http://www.cdc.gov/vaccines/pubs/acip-list.htm. Clinically significant adverse
events that follow immunization should be reported to the Vaccine Adverse Event
Reporting System (VAERS) at http://www.vaers.hhs.gov or by telephone,
800-822-7967.
1.
Hepatitis B vaccine (HepB). (Minimum age: birth)
At birth:
•
Administer monovalent HepB to all newborns before hospital discharge.
•
If mother is hepatitis B surface antigen (HBsAg)-positive, administer HepB
and 0.5 mL of hepatitis B immune globulin (HBIG) within 12 hours of birth.
•
If mother’s HBsAg status is unknown, administer HepB within 12 hours of
birth. Determine mother’s HBsAg status as soon as possible and, if HBsAg-
positive, administer HBIG (no later than age 1 week).
After the birth dose:
•
The HepB series should be completed with either monovalent HepB or a com-
bination vaccine containing HepB. The second dose should be administered
at age 1 or 2 months. Monovalent HepB vaccine should be used for doses
administered before age 6 weeks. The final dose should be administered no
earlier than age 24 weeks.
•
Infants born to HBsAg-positive mothers should be tested for HBsAg and
antibody to HBsAg 1 to 2 months after completion of at least 3 doses of the
HepB series, at age 9 through 18 months (generally at the next well-child
visit).
•
Administration of 4 doses of HepB to infants is permissible when a combina-
tion vaccine containing HepB is administered after the birth dose. The fourth
dose should be administered no earlier than age 24 weeks.
Inactivated poliovirus vaccine (IPV) (Minimum age: 6 weeks)
•
The final dose in the series should be administered on or after the fourth
birthday and at least 6 months following the previous dose.
•
If 4 doses are administered prior to age 4 years a fifth dose should be admin-
istered at age 4 through 6 years. See MMWR 2009;58(30):829–30.
2.
Influenza vaccine (seasonal). (Minimum age: 6 months for trivalent inacti-
vated influenza vaccine [TIV]; 2 years for live, attenuated influenza vaccine
[LAIV])
•
Administer annually to children aged 6 months through 18 years.
•
For healthy children aged 2 through 6 years (i.e., those who do not have under-
lying medical conditions that predispose them to influenza complications),
either LAIV or TIV may be used, except LAIV should not be given to children
aged 2 through 4 years who have had wheezing in the past 12 months.
•
Children receiving TIV should receive 0.25 mL if aged 6 through 35 months
or 0.5 mL if aged 3 years or older.
•
Administer 2 doses (separated by at least 4 weeks) to children aged younger
than 9 years who are receiving influenza vaccine for the first time or who were
vaccinated for the first time during the previous influenza season but only
received 1 dose.
•
For recommendations for use of influenza A (H1N1) 2009 monovalent vaccine
see MMWR 2009;58(No. RR-10).
* * * Free Preview End * * *
Purchase Required To Gain Total Access